TABLE 3-4 Minority/Special Populations Awards (CRISP 1997; last update January 20, 1998)

Activity Code

No. of Awards

Award Amount

F31

2

$30,814

F32

1

28,600

K07

3

161,095

N01

9

14,408,361

P01

4

704,346

P30

8

1,307,744

P50

2

367,519

R01

59

17,514,524

R03

12

1,297,779

R13

1

50,000

R25

12

1,445,109

R29

1

132,937

R43

2

199,493

R44

3

1,022,700

U01

4

3,967,931

U10

5

1,175,872

Total

128

43,903,168

 

SOURCE: National Cancer Institute.

Among these awards, NCI reports that 59 R01 awards—the principal NIH research mechanism for investigator-initiated awards—totaling more than $17.5 million were provided. Nine N01 awards totaling $14.4 million were granted. The awards principally support the PLCO Cancer Screening Trial and the recruitment of minority individuals into these screening trials. Twelve R03 and R25 awards supported small grants for time- and scope-limited projects (these were primarily projects to stimulate recruitment and retention of minorities in clinical trials) (nearly $1.3 million) and educational projects to develop programs in areas of education, information, technical assistance, or evaluation ($1.44 million), respectively. Eight P30 center core grant awards totaling $1.3 million were made to consortiums, including the Charles R. Drew University of Medicine and Science in Los Angeles. Nearly $4 million in funding was provided to support four U01 cooperative agreements, including the minority-serving leadership initiatives. A total of $704,000 in four P01 awards was awarded to support broad-based, multidisciplinary research. Many other awards were provided in other categories (see Table 3-4 for details).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement